Bruker Adjusts Guidance Amid Biopharma Challenges and Struggles in China
Daily NewsBruker Corporation (NASDAQ: BRKR), a global scientific instruments company, reported a revenue increase of 16.4% year-over-year in the third quarter of 2024, reac...
Read More